Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-06T10:13:24.753Z Has data issue: false hasContentIssue false

Novartis AG v. Union of India and Others

India.  01 April 2013 .

Published online by Cambridge University Press:  01 January 2021

Get access

Abstract

Relationship of international law and municipal law — Treaties — Agreement on Trade-Related Aspects of Intellectual Property Rights, 1994 (“TRIPS Agreement”) — India’s obligations under TRIPS Agreement — Compatibility with Indian patent law — Changes in Indian patent law — Patent Act — Legislative history — Patent Act 1970 amended in 2005 — Interpretation — Section 3(d) of Patent Act — Whether drug of pharmaceutical company having enhanced efficacy — Whether pharmaceutical company could patent drug — Whether drug satisfying test of patentability or invention under Patent Act — Whether Section 3(d) of Patent Act applicable

Treaties — Application — TRIPS Agreement — Doha Declaration on the TRIPS Agreement and Public Health 2001 — India’s treaty obligations — International developments impacting on Indian patent regime — Changes to Indian patent law — Patent Act 1970 amended in 2005 — Section 3(d) of Patent Act — Whether applicable — Whether pharmaceutical company could patent drug — Whether drug satisfying test of patentability or invention under Patent Act — Whether drug having enhanced efficacy — Whether Section 3(d) of Patent Act applicable

Economics, trade and finance — Intellectual property rights — World Trade Organization rules on intellectual property — TRIPS Agreement — Doha Declaration on the TRIPS Agreement and Public Health 2001 — Harmonization of Indian patent law — Indian Patent Act 1970 as amended in 2005 — Patent protection for pharmaceutical products — Whether pharmaceutical company could patent drug — Whether drug satisfying test of patentability or invention under Patent Act — Whether Section 3(d) of Patent Act applicable

Human rights — Right to health care — Public health concerns — TRIPS Agreement — Doha Declaration on the TRIPS Agreement and Public Health 2001 — Indian Patent Act — Whether meeting public health concerns — Whether pharmaceutical company could patent drug — Whether drug satisfying test of patentability or invention under Patent Act — Whether Section 3(d) of Patent Act applicable — The law of India

Type
Case Report
Copyright
© Cambridge University Press 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)